Legal & General Group Plc raised its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 14.3% during the third quarter, Holdings Channel.com reports. The institutional investor owned 5,753,982 shares of the company’s stock after purchasing an additional 720,469 shares during the quarter. Legal & General Group Plc’s holdings in Corteva were worth $389,142,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Activest Wealth Management grew its position in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares in the last quarter. True Wealth Design LLC raised its position in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. purchased a new stake in Corteva during the second quarter valued at about $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva during the second quarter worth about $29,000. Finally, Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $29,000. 81.54% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.14% of the stock is owned by insiders.
Analysts Set New Price Targets
View Our Latest Stock Report on Corteva
Corteva Trading Up 3.1%
Shares of CTVA opened at $78.65 on Thursday. The stock has a market capitalization of $52.89 billion, a P/E ratio of 49.78, a PEG ratio of 2.61 and a beta of 0.72. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a fifty day simple moving average of $73.63 and a two-hundred day simple moving average of $69.13.
Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. During the same period last year, the firm earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 45.57%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- “This AI Giant is About to Go Bust”
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
- Is Trump Done? Shocking leak…
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
